The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1.

PubWeight™: 3.65‹?› | Rank: Top 1%

🔗 View Article (PMC 2148176)

Published in J Cell Biol on August 10, 1998

Authors

G Serini1, M L Bochaton-Piallat, P Ropraz, A Geinoz, L Borsi, L Zardi, G Gabbiani

Author Affiliations

1: Department of Pathology, University of Geneva, 1211 Geneva 4, Switzerland.

Articles citing this

(truncated to the top 100)

Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol (2007) 5.60

Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell (2001) 4.25

NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med (2009) 4.05

Cardiac fibroblast: the renaissance cell. Circ Res (2009) 4.01

The immune system and cardiac repair. Pharmacol Res (2008) 3.42

Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol (2001) 3.07

TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J (1999) 3.05

Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol (2009) 2.93

Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). Am J Respir Crit Care Med (2005) 2.86

The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol (2009) 2.80

Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am J Respir Crit Care Med (2012) 2.65

The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol (1999) 2.56

Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell (2004) 2.29

Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol (2002) 2.23

Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol (2004) 2.17

Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int (2011) 2.15

Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build. Cell Mol Life Sci (2013) 2.14

Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol (2004) 2.09

Fibroblast heterogeneity in the cancer wound. J Exp Med (2014) 2.09

The pathogenesis of cardiac fibrosis. Cell Mol Life Sci (2013) 1.96

An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med (2007) 1.91

The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J Cell Biol (2002) 1.82

Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis. Arthritis Res Ther (2005) 1.81

NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol (2009) 1.80

New insights into form and function of fibronectin splice variants. J Pathol (2008) 1.80

Fibroblasts and myofibroblasts in renal fibrosis. Int J Exp Pathol (2011) 1.76

Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol (2003) 1.75

The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol (2013) 1.73

FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling. Sci Transl Med (2014) 1.72

Alpha-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Mol Biol Cell (2003) 1.70

Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am J Pathol (2006) 1.70

Fibronectins in vascular morphogenesis. Angiogenesis (2009) 1.66

Fibroblasts in myocardial infarction: a role in inflammation and repair. J Mol Cell Cardiol (2013) 1.61

Tryptase/Protease-activated receptor 2 interactions induce selective mitogen-activated protein kinase signaling and collagen synthesis by cardiac fibroblasts. Hypertension (2011) 1.61

Biomechanical regulation of blood vessel growth during tissue vascularization. Nat Med (2009) 1.58

Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis. J Pathol (2012) 1.57

NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts. Thorax (2010) 1.56

The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol (2011) 1.55

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med (2014) 1.54

The role of tumour stroma in colorectal cancer invasion and metastasis. Cancers (Basel) (2011) 1.50

Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol (2005) 1.46

The extracellular matrix: an active or passive player in fibrosis? Am J Physiol Gastrointest Liver Physiol (2011) 1.46

Focal adhesion kinase (FAK)-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner. J Biol Chem (2008) 1.42

Plasma and cellular fibronectin: distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair (2011) 1.41

Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus. PLoS One (2012) 1.41

Fibroblasts in post-infarction inflammation and cardiac repair. Biochim Biophys Acta (2012) 1.41

Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am J Pathol (2004) 1.39

Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Dev Biol (2007) 1.38

Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells. FASEB J (2008) 1.37

Characterisation of corneal fibrotic wound repair at the LASIK flap margin. Br J Ophthalmol (2003) 1.36

Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis. Mol Cell Biol (2004) 1.34

Extracellular matrix roles during cardiac repair. Life Sci (2010) 1.32

TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids. Respir Res (2009) 1.32

A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev Cell (2012) 1.29

Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali. Am J Pathol (2005) 1.27

The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res (2016) 1.27

Myofibroblasts: trust your heart and let fate decide. J Mol Cell Cardiol (2013) 1.25

Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy? Semin Cell Dev Biol (2009) 1.23

Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation. EMBO J (2005) 1.22

Fibroblasts and myofibroblasts in wound healing. Clin Cosmet Investig Dermatol (2014) 1.22

The bladder extracellular matrix. Part I: architecture, development and disease. Nat Rev Urol (2009) 1.19

FAK is required for TGFbeta-induced JNK phosphorylation in fibroblasts: implications for acquisition of a matrix-remodeling phenotype. Mol Biol Cell (2007) 1.19

CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis. Am J Physiol Heart Circ Physiol (2011) 1.14

Cell-matrix interactions in dermal repair and scarring. Fibrogenesis Tissue Repair (2010) 1.11

Fibronectin protects from excessive liver fibrosis by modulating the availability of and responsiveness of stellate cells to active TGF-β. PLoS One (2011) 1.11

Mechanoregulation of the Myofibroblast in Wound Contraction, Scarring, and Fibrosis: Opportunities for New Therapeutic Intervention. Adv Wound Care (New Rochelle) (2013) 1.10

Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair. J Cell Sci (2012) 1.09

Induction of vascular smooth muscle alpha-actin gene transcription in transforming growth factor beta1-activated myofibroblasts mediated by dynamic interplay between the Pur repressor proteins and Sp1/Smad coactivators. Mol Biol Cell (2004) 1.09

The role of macrophages in healing the wounded lung. Int J Exp Pathol (2012) 1.06

Scar wars: is TGFbeta the phantom menace in scleroderma? Arthritis Res Ther (2006) 1.05

Control of fibroblast fibronectin expression and alternative splicing via the PI3K/Akt/mTOR pathway. Exp Cell Res (2010) 1.04

Tenascin-C deficiency attenuates TGF-ß-mediated fibrosis following murine lung injury. Am J Physiol Lung Cell Mol Physiol (2010) 1.03

Cellular sources of extracellular matrix in hepatic fibrosis. Clin Liver Dis (2008) 1.03

RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species. Am J Physiol Renal Physiol (2014) 1.02

Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis. Am J Physiol Lung Cell Mol Physiol (2013) 1.02

Microvascular remodeling and wound healing: a role for pericytes. Int J Biochem Cell Biol (2012) 1.01

The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium. J Cardiovasc Transl Res (2012) 1.01

Localization of TGF-beta type II receptor and ED-A fibronectin in normal conjunctiva and failed filtering blebs. Mol Vis (2008) 1.01

TRPV1 involvement in inflammatory tissue fibrosis in mice. Am J Pathol (2011) 1.01

Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells. Histochem Cell Biol (2012) 1.00

Nuclear factor I-C links platelet-derived growth factor and transforming growth factor beta1 signaling to skin wound healing progression. Mol Cell Biol (2009) 1.00

Perspectives on tissue interactions in development and disease. Curr Mol Med (2010) 1.00

Epithelial-mesenchymal interactions in pulmonary fibrosis. Semin Respir Crit Care Med (2006) 0.99

Vascular wall extracellular matrix proteins and vascular diseases. Biochim Biophys Acta (2014) 0.99

Biomechanics of TGFβ-induced epithelial-mesenchymal transition: implications for fibrosis and cancer. Clin Transl Med (2014) 0.99

Regulation of alpha-smooth muscle actin expression in granulation tissue myofibroblasts is dependent on the intronic CArG element and the transforming growth factor-beta1 control element. Am J Pathol (2005) 0.99

The deletion of transforming growth factor-beta-induced myofibroblasts depends on growth conditions and actin organization. Am J Pathol (1999) 0.99

Dynamic protrusive cell behaviour generates force and drives early matrix contraction by fibroblasts. Exp Cell Res (2007) 0.99

The wound healing, chronic fibrosis, and cancer progression triad. Physiol Genomics (2014) 0.99

Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling. Pflugers Arch (2014) 0.98

Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis. Am J Pathol (2015) 0.98

Myofibroblasts: paracrine cells important in health and disease. Trans Am Clin Climatol Assoc (2000) 0.97

The lens as a model for fibrotic disease. Philos Trans R Soc Lond B Biol Sci (2011) 0.97

Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth. Cancers (Basel) (2015) 0.97

Actin cytoskeleton in myofibroblast differentiation: ultrastructure defining form and driving function. Transl Res (2011) 0.96

The myofibroblast, multiple origins for major roles in normal and pathological tissue repair. Fibrogenesis Tissue Repair (2012) 0.95

In vitro wounding: effects of hypoxia and transforming growth factor beta1 on proliferation, migration and myofibroblastic differentiation in an endothelial cell-fibroblast co-culture model. J Mol Histol (2007) 0.94

Coronary adventitial cells are linked to perivascular cardiac fibrosis via TGFβ1 signaling in the mdx mouse model of Duchenne muscular dystrophy. J Mol Cell Cardiol (2013) 0.94

Vascular involvement in systemic sclerosis (scleroderma). J Inflamm Res (2011) 0.93

Extracellular matrix and fibroblast communication following myocardial infarction. J Cardiovasc Transl Res (2012) 0.93

Articles cited by this

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature (1992) 16.46

TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature (1997) 15.75

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14

DNA repair defect tied to mutated TGF-beta receptor gene. Science (1995) 12.06

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A (1993) 10.82

Integrins and signal transduction pathways: the road taken. Science (1995) 10.71

Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem (1986) 10.00

Transforming growth factor beta in tissue fibrosis. N Engl J Med (1994) 9.73

Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol (1993) 8.36

A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol (1986) 6.83

The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev (1994) 5.65

Granulation tissue as a contractile organ. A study of structure and function. J Exp Med (1972) 5.42

Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev (1996) 5.17

Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev (1994) 5.04

Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest (1990) 4.67

Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol (1994) 4.60

Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest (1992) 4.49

The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell (1997) 4.11

PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell (1996) 3.60

Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol (1994) 3.57

Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol (1989) 3.44

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors (1993) 3.43

Transforming growth factor-beta: recent progress and new challenges. J Cell Biol (1992) 3.18

Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest (1990) 3.15

Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res (1984) 3.12

An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell (1997) 2.89

Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest (1993) 2.89

Integrins, oncogenes, and anchorage independence. J Cell Biol (1997) 2.86

Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol (1998) 2.83

Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc Natl Acad Sci U S A (1988) 2.73

Growth factors in the extracellular matrix. FASEB J (1997) 2.71

Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci U S A (1996) 2.63

Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry (1984) 2.49

A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem (1997) 2.26

Arginine-glycine-aspartic acid adhesion receptors. Methods Enzymol (1987) 2.25

Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol (1994) 2.18

Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest (1980) 2.16

Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J (1987) 1.98

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med (1996) 1.93

Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells. J Biol Chem (1988) 1.93

Fibronectin-associated transforming growth factor. J Cell Physiol (1987) 1.89

TGF-beta signalling through the Smad pathway. Trends Cell Biol (1997) 1.88

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nat Biotechnol (1997) 1.85

Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol (1995) 1.85

Extracellular matrix regulates expression of the TGF-beta 1 gene. J Cell Biol (1993) 1.84

The fibronectin gene as a model for splicing and transcription studies. FASEB J (1996) 1.81

A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol (1989) 1.73

Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. J Cell Biol (1987) 1.68

Alpha-smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by gamma-interferon. Exp Cell Res (1992) 1.64

Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett (1988) 1.61

Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent. J Cell Biol (1989) 1.54

Neurite extension of chicken peripheral nervous system neurons on fibronectin: relative importance of specific adhesion sites in the central cell-binding domain and the alternatively spliced type III connecting segment. J Cell Biol (1988) 1.49

Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment. J Cell Biol (1997) 1.35

Role of transforming growth factor-beta in chondrogenic pattern formation in the embryonic limb: stimulation of mesenchymal condensation and fibronectin gene expression by exogenenous TGF-beta and evidence for endogenous TGF-beta-like activity. Dev Biol (1991) 1.35

Transforming growth factor-beta regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett (1990) 1.28

Rat fibroblasts cultured from various organs exhibit differences in alpha-smooth muscle actin expression, cytoskeletal pattern, and adhesive structure organization. Exp Cell Res (1998) 1.27

Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects. Virchows Arch (1996) 1.25

Localization of the cellular-fibronectin-specific epitope recognized by the monoclonal antibody IST-9 using fusion proteins expressed in E. coli. FEBS Lett (1987) 1.24

Expression of fibronectin variants in vascular and visceral smooth muscle cells in development. Dev Biol (1990) 1.24

Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol (1997) 1.21

A simplified procedure for the preparation of antibodies to serum fibronectin. J Immunol Methods (1980) 1.13

Transforming growth factor beta increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts. Mol Cell Biol (1988) 1.12

Fibronectin mRNA splice variant in articular cartilage lacks bases encoding the V, III-15, and I-10 protein segments. J Biol Chem (1996) 1.09

Fibronectin type III5 repeat contains a novel cell adhesion sequence, KLDAPT, which binds activated alpha4beta1 and alpha4beta7 integrins. J Biol Chem (1997) 1.08

Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region. Functional significance. Am J Pathol (1990) 1.07

The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence. J Biol Chem (1992) 1.07

Fibronectin type III repeats mediate RGD-independent adhesion and signaling through activated beta1 integrins. J Biol Chem (1997) 1.05

Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts. Am J Pathol (1996) 1.03

Tumor targeting potential of the monoclonal antibody BC-1 against oncofetal fibronectin in nude mice bearing human tumor implants. Cancer (1997) 0.95

TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin. Histochem J (1995) 0.93

Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs. Am J Pathol (1997) 0.90

The region encoded by the alternatively spliced exon IIIA in mesenchymal fibronectin appears essential for chondrogenesis at the level of cellular condensation. Dev Biol (1997) 0.90

Modulation of alpha-smooth muscle actin expression in fibroblasts by transforming growth factor-beta isoforms: an in vivo and in vitro study. Wound Repair Regen (2006) 0.90

Adhesion activity in fibronectin's alternatively spliced domain EDa (EIIIA) and its neighboring type III repeats: oncogene-dependent regulation. Exp Cell Res (1994) 0.88

A pilot pharmacokinetic and immunoscintigraphic study with the technetium-99m-labeled monoclonal antibody BC-1 directed against oncofetal fibronectin in patients with brain tumors. Cancer (1997) 0.85

Plasminogen activator expression in rat arterial smooth muscle cells depends on their phenotype and is modulated by cytokines. Circ Res (1998) 0.83

Cloned cDNA sequence for the human mesothelial protein 'mesosecrin' discloses its identity as a plasminogen activator inhibitor (PAI-1) and a recent evolutionary change in transcript processing. J Cell Sci (1989) 0.83

Extracellular matrix assembly. Methods Enzymol (1994) 0.78

Articles by these authors

Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol (1993) 8.36

A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol (1986) 6.83

Granulation tissue as a contractile organ. A study of structure and function. J Exp Med (1972) 5.42

Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia (1971) 5.14

Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest (1990) 4.67

Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell (2001) 4.25

Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol (1995) 4.00

Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res (1999) 3.78

Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells. Am J Pathol (1973) 3.36

Contraction of granulation tissue in vitro: similarity to smooth muscle. Science (1971) 3.29

Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest (1990) 3.15

Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol (2001) 3.07

Immunochemical identification of intermediate-sized filaments in human neoplastic cells. A diagnostic aid for the surgical pathologist. Am J Pathol (1981) 2.94

Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin. Proc Natl Acad Sci U S A (1981) 2.94

Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol (1992) 2.72

Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem (1997) 2.63

Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol (1994) 2.44

Dupuytren's contracture: fibroblast contraction? An ultrastructural study. Am J Pathol (1972) 2.31

Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest (1989) 2.30

Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem (1989) 2.23

Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest (1985) 2.16

Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening. Lab Invest (1984) 2.15

"Contractile interstitial cells" in pulmonary alveolar septa: a possible regulator of ventilation-perfusion ratio? Ultrastructural, immunofluorescence, and in vitro studies. J Cell Biol (1974) 2.11

Actin and tubulin co-cap with surface immunoglobulins in mouse B lymphocytes. Nature (1977) 2.10

The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem (1997) 2.09

Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer (1988) 2.01

Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest (1984) 1.95

The role of cytoskeletal and cytocontractile elements in pathologic processes. Am J Pathol (1983) 1.91

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nat Biotechnol (1997) 1.85

Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel. J Biol Chem (1998) 1.83

The myofibroblast: a quarter century after its discovery. Am J Surg Pathol (1998) 1.82

Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch (1994) 1.79

Phalloidin-induced hyperplasia of actin filaments in rat hepatocytes. Lab Invest (1975) 1.78

Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. J Cell Sci (2001) 1.75

A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol (1989) 1.73

Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J Exp Med (1989) 1.70

Myofibroblasts in human granulation tissue. Hum Pathol (1974) 1.68

Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. J Cell Biol (1987) 1.68

Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha. Am J Respir Crit Care Med (1995) 1.67

Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest (1996) 1.65

Cellular events and intracellular survival of Campylobacter jejuni during infection of HEp-2 cells. Infect Immun (1989) 1.65

Alpha-smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by gamma-interferon. Exp Cell Res (1992) 1.64

Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol (1991) 1.62

Malignant soft tissue tumors of probable histiocytic origin (malignant fibrous histiocytomas): general considerations and electron microscopic and tissue culture studies. Cancer (1975) 1.62

Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett (1988) 1.61

Lack of specificity of endoglin expression for tumor blood vessels. Int J Cancer (2001) 1.60

Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci (1987) 1.60

Effect of gamma-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study. Plast Reconstr Surg (1994) 1.58

Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis (1988) 1.57

Cytoplasmic filaments and gap junctions in epithelial cells and myofibroblasts during wound healing. J Cell Biol (1978) 1.52

Distribution of vimentin and desmin filaments in smooth muscle tissue of mammalian and avian aorta. Exp Cell Res (1982) 1.52

The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer (1994) 1.51

Elution of fibronectin proteolytic fragments from a hydroxyapatite chromatography column. A simple procedure for the purification of fibronectin domains. Eur J Biochem (1985) 1.51

Alpha-smooth muscle actin in parenchymal cells of bleomycin-injured rat lung. Lab Invest (1989) 1.50

The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J Cell Sci (1998) 1.49

The contractile fibroblast. Its relevance in plastic surgery. Plast Reconstr Surg (1973) 1.46

Intranuclear injection of anti-actin antibodies into Xenopus oocytes blocks chromosome condensation. Nature (1979) 1.45

Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol (1993) 1.44

Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol (1997) 1.44

Collagen and myofibroblasts of granulation tissue. A chemical, ultrastructural and immunologic study. Virchows Arch B Cell Pathol (1976) 1.43

Identification of self-renewing myoblasts in the progeny of single human muscle satellite cells. Differentiation (1996) 1.43

Cytoskeletal features of rat aortic cells during development. An electron microscopic, immunohistochemical, and biochemical study. Circ Res (1985) 1.43

Expression of emmprin by oral squamous cell carcinoma. Int J Cancer (2000) 1.42

Polarized distribution of actin isoforms in gastric parietal cells. Mol Biol Cell (1995) 1.41

An actin-destabilizing factor is present in human plasma. Experientia (1979) 1.41

Cytoplasmic contractile apparatus in aortic endothelial cells of hypertensive rats. Lab Invest (1975) 1.41

Fibroblasts of granulation tissue: immunofluorescent staining with antismooth muscle serum. Proc Soc Exp Biol Med (1971) 1.41

A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Hepatology (1999) 1.40

Alpha-smooth muscle actin is transiently expressed in embryonic rat cardiac and skeletal muscles. Differentiation (1988) 1.39

Colonic pericryptal fibroblasts. Differentiation pattern in embryogenesis and phenotypic modulation in epithelial proliferative lesions. Virchows Arch A Pathol Anat Histopathol (1989) 1.39

Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells. Hum Pathol (1986) 1.39

Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol (1995) 1.39

Transformed human cells release different fibronectin variants than do normal cells. J Cell Biol (1986) 1.37

Smooth muscle differentiation in scleroderma fibroblastic cells. Am J Pathol (1990) 1.36

Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. Studies with domain-specific antibodies. J Biol Chem (1985) 1.34

Vimentin-containing smooth muscle cells in aortic intimal thickening after endothelial injury. Lab Invest (1982) 1.34

Actin isoform synthesis and mRNA levels in quiescent and proliferating rat aortic smooth muscle cells in vivo and in vitro. Lab Invest (1986) 1.33

Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol (1997) 1.32

Increase of contractile proteins in human cancer cells. Lancet (1975) 1.32

Cytodifferentiation and expression of alpha-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state. Arteriosclerosis (1989) 1.32

Locally applied GM-CSF induces the accumulation of alpha-smooth muscle actin containing myofibroblasts. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 1.31

Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies. Nucleic Acids Res (1991) 1.31

Interferon-gamma inhibits experimental renal fibrosis. Kidney Int (1999) 1.30

Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma. Hepatology (1992) 1.30

Transforming growth factor-beta regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett (1990) 1.28

Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation (2001) 1.28

Rat fibroblasts cultured from various organs exhibit differences in alpha-smooth muscle actin expression, cytoskeletal pattern, and adhesive structure organization. Exp Cell Res (1998) 1.27

Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension (1998) 1.25

Actin microfilaments, cell shape, and secretory processes in isolated rat hepatocytes. Effect of phalloidin and cytochalasin D. J Cell Biol (1979) 1.25

Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies. Lab Invest (1991) 1.25

Fibronectin: a chromatin-associated protein? Cell (1979) 1.25